Somafina, a nutraceutical manufacturing company based in Cedartown, Georgia, has acquired Layton’s UST Corp., a contract manufacturer of vitamins, minerals and supplements. Somafina is a portfolio company of Norwalk, Connecticut-based private equity firm Heartwood Partners.
UST Corp. offers an end-to-end solution for its customers, ranging from formulation and product development to production and packaging. In addition, with an ISO-certified in-house testing lab, UST produces science-based supplement types and formats.
“We are deeply excited to partner with UST,” said John Niemi, CEO of Somafina. “Situated in a key hub of nutraceutical supplement manufacturing in Greater Salt Lake City and with significant production capacity, UST is on an exciting growth path. Our combined production capabilities, spanning across capsule, gummy, powder and liquid format manufacturing, means Somafina is well-situated to service the broad product set requirements of our supplement brand customers moving forward.”
“We are thrilled with this strategic add-on acquisition and Somafina’s potential moving forward,” said James Sidwa, a partner at Heartwood Partners. “Somafina continues to expand its capabilities across manufacturing, ingredient formulation and quality with the focused goal of supporting its customers.”
“The acquisition and integration of UST enables Somafina to offer the highest quality in nutritional supplements, attractive lead times, and flexibility,” added Niemi. “Their two-decade track-record of growth and innovation in the nutraceutical category is unmatched.”